Clinical Trial Update: A Phase I, Dose-Escalation Study to Assess the Safety and Drug Levels in Blood of AZD4877 in Japanese Adult Patients [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase I dose-escalation trial of AZD4877 in Japanese adults to evaluate safety and pharmacokinetics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Carcinoma

Drugs mentioned

• AZD4877

Snippet

Sponsor: AstraZeneca | Conditions: Cancer, Tumors | Phase 1 | Status: COMPLETED